MRK - Merck & Co., Inc.
Close
99.65
0.030 0.030%
Share volume: 126,042
Last Updated: Fri 27 Dec 2024 08:30:15 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$99.62
0.03
0.03%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-05 | 2022-11-03 | 2023-02-24 | 2023-05-05 | 2023-08-07 | 2023-11-03 | 2024-02-26 | 2024-05-03 | |
Total revenue | 14.593 B | 14.959 B | 13.830 B | 14.487 B | 15.035 B | 15.962 B | 14.631 B | 15.775 B | |
Cost of revenue | 4.216 B | 3.934 B | 3.881 B | 3.926 B | 4.024 B | 4.264 B | 3.912 B | 3.540 B | |
Gross profit | 10.377 B | 11.025 B | 9.949 B | 10.561 B | 11.011 B | 11.698 B | 10.719 B | 12.235 B | |
6.24% | -9.76% | 6.15% | 4.26% | 6.24% | -8.37% | 14.14% | |||
Operating expenses | 5.310 B | 6.919 B | 6.462 B | 6.755 B | 16.023 B | 5.826 B | 12.431 B | 6.475 B | |
Selling general and admin | 2.512 B | 2.520 B | 2.687 B | 2.479 B | 2.702 B | 2.519 B | 2.804 B | 2.483 B | |
Research and development | 2.798 B | 4.399 B | 3.775 B | 4.276 B | 13.321 B | 3.307 B | 9.627 B | 3.992 B | |
Total expenses | 9.810 B | 11.224 B | 8.980 B | 10.681 B | 20.047 B | 10.090 B | 16.343 B | 10.015 B | |
14.41% | -19.99% | 18.94% | 87.69% | -49.67% | 61.97% | -38.72% | |||
Operating income | 4.783 B | 3.735 B | 4.850 B | 3.806 B | -5.012 B | 5.872 B | -1.712 B | 5.760 B | |
Ebit | 4.783 B | 3.735 B | 4.850 B | 3.806 B | -5.012 B | 5.872 B | -1.712 B | 5.760 B | |
Pretax income | 4.487 B | 3.583 B | 3.513 B | 3.650 B | -5.335 B | 5.620 B | -2.046 B | 5.670 B | |
-20.15% | -1.95% | 3.90% | -246.16% | -205.34% | -136.41% | -377.13% | |||
Income tax | 538.000 M | 330.000 M | 496.000 M | 825.000 M | 637.000 M | 870.000 M | -820.000 M | 903.000 M | |
Net income basic | 3.944 B | 3.248 B | 3.017 B | 2.821 B | -5.975 B | 4.745 B | -1.226 B | 4.762 B | |
-17.65% | -7.11% | -6.50% | -311.80% | 179.41% | -125.84% | 488.42% | |||
Net income | 3.944 B | 3.248 B | 3.017 B | 2.821 B | -5.975 B | 4.745 B | -1.226 B | 4.762 B | |
-17.65% | -7.11% | -6.50% | -311.80% | 179.41% | -125.84% | 488.42% |